MAPAX
Price
$31.33
Change
+$0.15 (+0.48%)
Updated
Jul 25 closing price
Net Assets
952.03M
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

MAPAX vs VIVIX

Header iconMAPAX vs VIVIX Comparison
Open Charts MAPAX vs VIVIXBanner chart's image
NYLI WMC Value
Price$31.33
Change+$0.15 (+0.48%)
VolumeN/A
Net Assets952.03M
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
MAPAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPAX vs. VIVIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. MAPAX (952M). VIVIX pays higher dividends than MAPAX: VIVIX (2.19) vs MAPAX (1.39). MAPAX was incepted earlier than VIVIX: MAPAX (26 years) vs VIVIX (27 years). MAPAX (1.02) is less costly to investors than VIVIX (0.04). MAPAX is a more actively managed with annual turnover of: 38.00 vs. VIVIX (9.00). MAPAX has a lower initial minimum investment than VIVIX: MAPAX (15000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.75 vs. MAPAX (6.20). VIVIX return over 5 years is better than : 74.87 vs. MAPAX (-14.64).
MAPAXVIVIXMAPAX / VIVIX
Total Expense Ratio1.020.042,550%
Annual Report Gross Expense Ratio1.020.042,550%
Fund Existence26 years27 years-
Gain YTD6.8926.730102%
Front Load6%N/A-
Min. Initial Investment1500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets952M195B0%
Annual Yield % from dividends1.392.1963%
Returns for 1 year6.209.7564%
Returns for 3 years17.9434.3252%
Returns for 5 years-14.6474.87-20%
Returns for 10 years-25.13116.26-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLAY3.740.06
+1.63%
Relay Therapeutics
INCR1.550.01
+0.65%
Intercure Ltd
EXPD116.70-0.14
-0.12%
Expeditors International of Washington
XIFR9.52-0.07
-0.73%
XPLR Infrastructure LP
NLSP1.98-0.18
-8.33%
Nls Pharmaceutics Ltd